Trevena to Release First Quarter 2020 Financial Results on May 7, 2020


CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it will release its financial results for the first quarter ended March 31, 2020, prior to the market open on Thursday, May 7, 2020.

Company management will host a conference call and webcast to discuss its financial results and provide a general business update at 8:00 a.m. (ET) on the same day, featuring remarks by Carrie Bourdow, President and Chief Executive Officer, Bob Yoder, SVP and Chief Business Officer, Mark Demitrack, SVP and Chief Medical Officer, and Barry Shin, SVP and Chief Financial Officer.

Title: Trevena First Quarter 2020 Financial Results Conference Call & Webcast

Date: Thursday, May 7, 2020

READ:  Zynerba Pharmaceuticals Changes Annual Meeting of Shareholders to Virtual-Only Format

Time: 8:00 a.m. ET

Conference Call Details:

Toll-Free: 855-465-0180
International: 484-756-4313
Conference ID: 5469527

The conference call will be webcast live from the company’s website and will be available via the following links:



The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the company’s website.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee

Leave a Reply

Notify of